Results 221 to 230 of about 350,788 (241)
Some of the next articles are maybe not open access.
Adjuvant Chemotherapy for Cholangiocarcinoma
2021Surgical resection is the only curative treatment modality for cholangiocarcinoma; however, patients often develop recurrence because of its malignant nature. Therefore, the development of adjuvant therapy is urgently needed to improve the prognosis of this disease.
openaire +2 more sources
Adjuvant Chemotherapy for Sarcomas and Carcinomas
Veterinary Clinics of North America: Small Animal Practice, 1990The use of adjuvant chemotherapy appears to offer many advantages to the patient with cancer. However, objective information is difficult to compile. Clinical trials all too often have only a small number of patients. In order to best demonstrate the usefulness of adjuvant chemotherapy, many of the cases discussed here had bulky disease.
A S Hammer, C. Guillermo Couto
openaire +3 more sources
Chemotherapy as an adjuvant to surgery
The American Journal of Surgery, 1963Abstract To date, all of the Adjuvant Chemotherapy Studies with the exception of the Breast Study are essentially negative in terms of survival. However, much valuable information has come from these studies. It has become apparent that valid, meaningful data can be collected rapidly and safely by cooperating personnel in surgical clinics using a ...
George E. Moore +2 more
openaire +2 more sources
Chemotherapy as an Adjuvant to Radiotherapy
1967The rationale of combining a chemotherapeutic agent with radiation therapy can be on one of two hypotheses: 1. Agents like 5-fluorouracil (5-FU) or 5-bromodeoxyuridine (5-BUdR) have been shown to be radiation sensitizers (Bagshaw, 1961; Berry and Andrews, 1962; Bosch et al., 1958; Djordjevic and Szybalski, 1960, Kaplan et al., 1961, 1962 ...
Robert D. Lindberg +6 more
openaire +2 more sources
Neoadjuvant and Adjuvant Chemotherapy
2020Even though the cornerstone of treatment for gallbladder cancer is curative surgical resection, more than two-thirds of the patients are diagnosed with the metastatic condition. Furthermore, prognosis after curative surgery is still poor with a 5-year survival rate less than 5%. Chemotherapy is the main therapeutic option for these situations.
openaire +2 more sources
Adjuvant Chemotherapy: Correct Advice?
JAMA: The Journal of the American Medical Association, 1977To the Editor.— We take exception to suggestions made by Dr Turnbull for adjuvant chemotherapy in a case of Dukes stage C colonic cancer (237:385, 1977). Dr Turnbull correctly states that the adjuvant use of fluorouracil and semustine (methyl-CCNU) is investigational with insufficient long-term experience, and yet he goes on to recommend adjuvant ...
Franco M. Muggia +3 more
openaire +3 more sources
2018
Radical cystectomy (RC) is considered a standard of care for patients with muscle-invasive bladder cancer. After RC, pathologically higher stages (≥T3) and lymph node positive patients had poor survival outcomes. This problem can be addressed with the use of systemic chemotherapy.
openaire +2 more sources
Radical cystectomy (RC) is considered a standard of care for patients with muscle-invasive bladder cancer. After RC, pathologically higher stages (≥T3) and lymph node positive patients had poor survival outcomes. This problem can be addressed with the use of systemic chemotherapy.
openaire +2 more sources
Adjuvant Chemotherapy in Breast Cancer
1982One single course of i.v. cyclophosphamide (30 mg/kg) was given over a 6-day period to 559 mastectomized patients. During a follow-up period of up to 15 years, 241 recurrence and 234 deaths are registered in this group, and 294 recurrences and 283 deaths in the randomized control group of 577 patients.
R. Nissen-Meyer +2 more
openaire +3 more sources
Adjuvant chemotherapy in renal leiomyosarcoma
Urology, 1979Our encounter with a patient with renal leiomyosarcoma prompted a survey of the world literature in which 84 cases were found. The use of chemotherapy after nephrectomy is advocated since our patient survived more than four years without metastases. The rationale for our chemotherapeutic protocol is discussed.
David J. Beccia +2 more
openaire +2 more sources
Adjuvant Chemotherapy of Breast Cancer
New England Journal of Medicine, 1981To the Editor.— As a practicing oncologist, I read with anticipation the recent MEDICAL NEWS article on the adjuvant chemotherapy of breast cancer (1980;244:1079). Several areas of controversy were touched on; the most interesting was the question of whether adjuvant therapy should be used in women with negative nodes.
openaire +6 more sources